TAKE Limited Share Price & Company Info
- Market cap
- ₹158 Cras reported by NSE
- 52-week high
- ₹50.1420-APR-2026
- 52-week low
- ₹9.8827-OCT-2026
- P/E (NSE)
- 12.30
- Face value
- ₹1.00
- Shares issued
- 14,79,34,000
- Volume
- 1,43,077₹0.18 Cr traded
- Delivery
- 66.02%of traded quantity
- Price band
- 5%₹10.51 – ₹11.61 on 2026-11-02
- Annual volatility
- 66.29%NSE, from daily returns
- Series
- EQrolling settlement
- BSE group
- Bscrip code 532890
- ISIN
- INE142I01023
- Listed on NSE
- 27-Aug-2007
About TAKE Limited
TAKE Limited is listed on the National Stock Exchange of India under the symbol TAKE in the EQ series. NSE classifies it under the basic industry Healthcare Research Analytics & Technology, part of the Healthcare sector. Its shares were listed on NSE on 27-Aug-2007. Each share has a face value of ₹1.00.
In the end-of-day data for 16 November 2026 the stock closed at ₹12.84, down 1.15% on the day. NSE puts the company's market capitalisation at about ₹158 crore, which puts it among the smallest listed companies in India. Over the past 52 weeks it has traded between ₹9.88 and ₹50.14, so the last price is 30.0% above the low and 74.4% below the high.
1,43,077 shares changed hands that day, and 66.02% of them were taken as delivery rather than squared off intraday. A high delivery share means most of the day's buyers chose to hold the shares; a low one usually means the volume was mostly short-term trading.
EQ is the normal equity series: shares settle on the usual T+1 cycle and intraday trading is allowed.
NSE currently lists a regulatory note for this stock: “High low price var. was greater than 75% in prev. 3 mths. | High low price var. was greater than 300% in prev. 365 days | High low price var. was greater than 100% in prev. 6 mths”. Notes like these come from the exchange's surveillance and disclosure checks and can mean higher margins, trade-for-trade settlement or limits on trading. Check the NSE quote page for the current position before trading.
NSE puts the stock's annualised volatility at 66.29%. That is very high: moves of several percent in a single day are routine.
Because the share trades below ₹20, it also appears in our list of penny stocks under ₹20, which explains the extra risks that come with low-priced shares.
TAKE Limited quarterly results
In the quarter ended June 2026 (un-audited), TAKE Limited reported total income of ₹13.30 crore and a net profit of ₹0.97 crore, or ₹0.07 per share. That is a net margin of 7.3% on income.
A year earlier, in the June 2025 quarter, income was ₹0.01 crore with a net loss of ₹2.16 crore. Income has grown 132900.0% year on year. The company has swung from a loss to a profit over that year.
TAKE Limited was profitable in 3 of the 5 quarters shown below. Figures are as filed with NSE, in ₹ crore.
| Quarter ended | Total income | Profit before tax | Net profit | EPS | Status |
|---|---|---|---|---|---|
| June 2026 | 13.30 | 0.97 | 0.97 | 0.07 | Un-Audited |
| March 2026 | 5.18 | 4.39 | 4.39 | 0.30 | Audited |
| December 2025 | 1.46 | 1.11 | 1.11 | 0.08 | Un-Audited |
| September 2025 | -0.03 | -0.47 | -0.62 | -0.04 | Un-Audited |
| June 2025 | 0.01 | -2.16 | -2.16 | -0.15 | Un-Audited |
TAKE Limited shareholding pattern
TAKE Limited has no promoter or promoter group: the filing for September 2026 shows 100% of its shares held by the public. That usually means the original promoters have exited, for example after a debt restructuring, so no single family or parent company controls the board through its shareholding.
| Quarter ended | Promoter & Promoter Group (%) | Public (%) |
|---|---|---|
| September 2026 | — | 100.00 |
| June 2026 | — | 100.00 |
| March 2026 | — | 100.00 |
| December 2025 | — | 100.00 |
| September 2025 | 5.19 | 94.81 |
| June 2025 | 53.34 | 46.66 |
| March 2025 | 53.41 | 46.59 |
| December 2024 | 53.41 | 46.59 |
TAKE Limited share price performance
Over the past year the TAKE Limited share price has lost 52.55%, against a fall of 10.92% for the NIFTY 50, so it has underperformed that index by 41.63 percentage points.
Across the 7 periods in the table, the stock did not beat the NIFTY 50 in any of them. Past returns describe what happened; they do not predict what comes next.
| Period | TAKE | NIFTY 50 |
|---|---|---|
| 1 month | -20.29% | +1.91% |
| 3 months | -48.42% | -5.20% |
| 6 months | -75.15% | -3.94% |
| 1 year | -52.55% | -10.92% |
| 2 years | -41.09% | -5.29% |
| 3 years | -45.45% | +20.44% |
| 5 years | -77.87% | +30.45% |
TAKE Limited vs industry peers
NSE compares TAKE Limited with 5 other listed companies in Healthcare Research Analytics & Technology. By market capitalisation it ranks 6 of 6, the smallest in the group.
Its P/E of 12.30 compares with a median of 33.11 for the other companies in the group: the market is paying considerably less for each rupee of its recent earnings.
| Company | Market cap | Price (₹) | P/E | Promoter % | Qtr income | Qtr net profit |
|---|---|---|---|---|---|---|
| SYNGENE | 16,268 | 403.00 | 64.14 | 52.59 | 688 | -2.10 |
| INDGN | 14,102 | 585.20 | 33.11 | 0.00 | 375 | 59.90 |
| SUVEN | 7,333 | 259.50 | — | 70.08 | 11.09 | -16.12 |
| VIMTALABS | 2,171 | 485.60 | 26.60 | 35.67 | 113 | 21.04 |
| BI | 177 | 75.33 | — | 0.00 | — | — |
| TAKE | 157 | 10.61 | 12.30 | 0.00 | 13.30 | 0.97 |
TAKE Limited announcements, board meetings and corporate actions
Latest announcements
The most recent filings TAKE Limited has made with NSE, newest first:
- 14-Oct-2026 · Certificate under SEBI (Depositories and Participants) Regulations, 2018: TAKE Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 (PDF)
- 01-Oct-2026 · Shareholders meeting: TAKE Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 29, 2026. Further, the company has informed the Exchange regarding voting results. (PDF)
- 29-Sep-2026 · Shareholders meeting: TAKE Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 29, 2026 (PDF)
- 25-Sep-2026 · Trading Window: TAKE Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 (PDF)
- 12-Sep-2026 · Record Date: TAKE Limited has informed the Exchange regarding Intimation of Cut-off Date for E-voting for the 25th Annual General Meeting. (PDF)
- 09-Sep-2026 · Copy of Newspaper Publication: TAKE Limited has informed the Exchange about Copy of Newspaper Publication (PDF)
- 07-Sep-2026 · Shareholders meeting: TAKE Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 29, 2026 (PDF)
- 05-Sep-2026 · Copy of Newspaper Publication: TAKE Limited has informed the Exchange about Copy of Newspaper Publication of 25th Annual General Meeting to be held through VC/OAVM Disclosure under Regulation 30 and 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (PDF)
Board meetings
- 11-Aug-2026 · Financial Results: To consider and approve the financial results for the period ended Jun 30, 2026
- 20-May-2026 · Financial Results/Other business matters: To consider and approve the financial results for the period ended March 31, 2026 and other business matters
- 14-Feb-2026 · Financial Results/Other business matters: To consider and approve the financial results for the period ended December 31, 2025 and other business matters
- 11-Feb-2026 · Other business matters: Board Meeting Intimation for Board Meeting To Be Held On Wednesday 11Th February 2026
- 27-Oct-2025 · Financial Results: To consider and approve the financial results for the period ended September 30, 2025
Corporate actions
The corporate actions on record include 5 dividends. The ex-date is the first day the shares trade without the entitlement.
- Annual General Meeting · ex-date 07-Aug-2024 · book closure 08-Aug-2024 to 14-Aug-2024
- Annual General Meeting · ex-date 07-Aug-2023 · book closure 08-Aug-2023 to 14-Aug-2023
- Annual General Meeting · ex-date 15-Dec-2022 · book closure 16-Dec-2022 to 23-Dec-2022
- Annual General Meeting · ex-date 02-Aug-2021 · book closure 04-Aug-2021 to 11-Aug-2021
- Annual General Meeting · ex-date 17-Sep-2020 · book closure 19-Sep-2020 to 25-Sep-2020
- Dividend - Re 0.40 Per Share · ex-date 01-Aug-2019 · book closure 03-Aug-2019 to 08-Aug-2019
- Interim Dividend - Re 0.30 Per Share · ex-date 22-Feb-2019 · record date 25-Feb-2019
- Interim Dividend - Re 0.30 Per Share · ex-date 09-Nov-2018 · record date 12-Nov-2018
- Annual General Meeting/Final Dividend- Re 0.40 Per Share/ Special Dividend- Re 0.60 Per Share (Purpose Revised) · ex-date 02-Aug-2018 · book closure 04-Aug-2018 to 10-Aug-2018
- Interim Dividend Re 0.30 Per Share (Purpose Revised) · ex-date 15-Feb-2018 · record date 19-Feb-2018
Risk notice: low-priced and small-company shares can be illiquid, volatile and subject to manipulation, and shareholders can lose their entire investment. This page is a factual summary, not a recommendation to buy or sell TAKE Limited.
Where to find TAKE Limited's financials
Direct downloads from NSE:
- Annual report 2025-26 (PDF, 3.54 MB)
- Annual report 2024-25 (PDF, 2.38 MB)
- Annual report 2023-24 (PDF)
- Annual report 2022-23 (ZIP)
- Annual report 2021-22 (ZIP)
- Annual report 2020-21 (ZIP)
For full financial statements, shareholding detail and every company announcement, go to the source:
- NSE quote pageOfficial price, price band, surveillance status, shareholding pattern and corporate actions.
- Annual reports (NSE)Search “TAKE” to download TAKE Limited's annual reports as filed with the exchange.
- Announcements and results (NSE)Search “TAKE” for quarterly results, board meetings and other company filings.
- BSE quote page (532890)BSE price, filings, results and shareholding for the same company.
- ScreenerTen years of profit and loss, balance sheet, cash flow and key ratios.
- TradingView chartInteractive price chart with technical indicators.
- Google FinanceQuick price overview and recent news coverage.
- Yahoo FinanceHistorical prices you can download, plus summary statistics.
Other Healthcare Research Analytics & Technology stocks on MCX Trends
- Syncom Formulations (India) Limited (SYNCOMF · ₹21.19)
- Anlon Healthcare Limited (AHCL · ₹25.77)
- Sigachi Industries Limited (SIGACHI · ₹28.16)
- Fischer Medical Ventures Limited (FISCHER · ₹23.86)
- Vineet Laboratories Limited (VINEETLAB · ₹37.52)
- Ambalal Sarabhai Enterprises Limited (AMBALALSA · ₹38.62)
- Medico Remedies Limited (MEDICO · ₹18.31)
- Nectar Lifesciences Limited (NECLIFE · ₹10.31)
Frequently asked questions
What is the TAKE Limited share price?
TAKE Limited (NSE: TAKE) closed at ₹12.84 in the end-of-day data for 16 November 2026. For a live price, use the NSE quote page or your broker, because this page is updated from end-of-day files.
Which sector does TAKE Limited belong to?
NSE classifies TAKE Limited under Healthcare Research Analytics & Technology, in the Healthcare sector.
What is the 52-week high and low of TAKE?
The 52-week high is ₹50.14 (20-APR-2026) and the 52-week low is ₹9.88 (27-OCT-2026), according to NSE.
Is TAKE Limited a penny stock?
At ₹12.84 the share trades below ₹20, so it appears on our list of penny stocks under ₹20. A low share price on its own says nothing about whether a company is cheap or expensive; market capitalisation, debt, profits and exchange surveillance status matter far more.
Who are the promoters of TAKE Limited?
TAKE Limited has no promoter group. Its latest shareholding filing with NSE, for September 2026, shows 100% of the shares held by the public.
What were TAKE Limited's latest quarterly results?
For the quarter ended June 2026, TAKE Limited reported total income of ₹13.30 crore and a net profit of ₹0.97 crore (EPS ₹0.07).
Where can I find TAKE Limited's annual report and financial results?
Annual reports, quarterly results and other filings are published on the NSE corporate filings pages (search for TAKE) and on BSE. Screener also lays out several years of financial statements in one place. Links to all of these are above.